510(k) Report

510(k) · Cleared

Cleared

OSOM Mono Test; Sure Vue Signature Mono; ImmunoCard STAT Mono; Cardinal Health Mono II Rapid Test

K181436510(k) SpecialCleared Jun 22, 201821-day reviewClass II21 CFR 866.5640

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

SEKISUI Diagnostics, LLC · KTN System, Test, Infectious Mononucleosis

Cleared on Jun 22, 2018 as substantially equivalent to K972231 (Wyntek Diagnostics, Inc., 1997) after a 21-day review. Its family tree reaches back 1 generation to 1997.

Decided
Jun 22, 2018
Review
21 days
Class
Class II
Product code
KTN
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K972231 (1997). No later device cites it as a predicate yet.

K972231 · Osom Mono Test 143 · Wyntek Diagnostics, Inc. · 1997199520002005201020152020
K972231 · Osom Mono Test 143 · Wyntek Diagnostics, Inc. · 19970
  1. Root · 1 generation backK972231 Osom Mono Test 143Wyntek Diagnostics, Inc. · 1997
  2. This deviceK181436 OSOM Mono Test; Sure Vue Signature Mono; ImmunoCard STAT Mono…SEKISUI Diagnostics, LLC · 2018
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K972231Osom Mono Test 143Wyntek Diagnostics, Inc.1997—
0 (this device)K181436OSOM Mono Test; Sure Vue Signature Mono; ImmunoCard STAT Mono; Cardinal Health…SEKISUI Diagnostics, LLC2018—
FIG. 1 — Lineage of K181436, 1997–2018Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KTN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K972231Osom Mono Test 143
Summary page 4
…se antibodies aid in the diagnosis of infectious mononucleosis IDENTIFICATION OF LEGALLY MARKETED PREDICATE DEVICES [807.92(A)(3)] Sekisui Diagnostics OSOM Mono Test, K972231 DESCRIPTION OF DEVICE [807.92 (A)(4)] The OSOM Mono Test uses color immunochromatographic dipstick technology with bovine eryt…
Wyntek Diagnostics, Inc.1997—

Also cleared against K972231: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • 1 other device also cites its predicate K972231.

How does its category compare?

All KTN devices

KTN System, Test, Infectious Mononucleosis: FDA decisions, review times, recalls and adverse event reports over 20 years. 2018, this device’s year, is highlighted.

FDA decisions per year · KTN

1in 2018

2018: 1
2007high 1 (2018) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KTN

Too few KTN 510(k)s in any year since 2007 to give a median.

Recalls per year · KTN

No recall names KTN since 2007.

Adverse event reports per year · KTN

1in 2024

2008: 22019: 22020: 22024: 1
2007high 2 (2008) · low 0 (2007)2025

MAUDE reports naming product code KTN, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—02
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20181—00
20190—02
20200—02
20210—00
20220—00
20230—00
20240—01
20250—00
20260—0—

What is it indicated for?

The OSOM® Mono Test is intended for the qualitative detection of infectious mononucleosis heterophile antibodies in serum, plasma or whole blood as an aid in the diagnosis of infectious mononucleosis.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K181436: OSOM Mono Test; Sure Vue Signature Mono; ImmunoCard STAT Mono; Cardinal Health Mono II Rapid Test.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K181436

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026